Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cholesterol Biosynthesis Pathway WP197,3.5163950196168323e-07,16.778140293637847,249.33422706608374,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'CYP51A1', 'SC5D', 'MSMO1', 'MVD', 'HMGCR', 'FDFT1']",0.00014143530326749375,0,0,10
2,Cytoplasmic Ribosomal Proteins WP477,5.880885790748181e-07,3.6636363636363636,52.559949700459285,"['RPL3', 'RPL12', 'RPLP0', 'RPL10A', 'RPS15A', 'RPL18A', 'RPL14', 'RPLP2', 'RPL38', 'RPL15', 'RPS27A', 'RPL18', 'RPL39', 'RPL17', 'RPS13', 'RPL19', 'RPS7', 'RPSA', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL26', 'FAU', 'RPS23']",0.00014143530326749375,0,0,26
3,"GPCRs, Class A Rhodopsin-like WP455",9.192924270602414e-06,4.334625997464389,50.26898916508858,"['GPR27', 'OPRD1', 'GPR12', 'P2RY14', 'CHRM5', 'F2R', 'GPR85', 'HTR2C', 'OPRK1', 'ADRA1D', 'NMBR', 'HTR4', 'HTR5A', 'MCHR1', 'HCRTR2', 'HRH1', 'MC1R']",0.0014739321913865872,0,0,17
4,Allograft Rejection WP2328,0.0005329719335398262,5.0244498777506115,37.869488713976295,"['ABCB1', 'TGFB1', 'COL5A1', 'HLA-B', 'HLA-C', 'HLA-A', 'VIM', 'HLA-F', 'VEGFA']",0.0640898750081641,0,0,9
5,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.0011346911057539889,3.3529411764705883,22.737617921221684,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'FASN', 'CYP51A1', 'ACOT2', 'SC5D', 'MSMO1', 'MVD', 'HMGCR', 'FDFT1']",0.10915728437353373,0,0,12
6,Aryl Hydrocarbon Receptor Pathway WP2873,0.0013767207634791305,4.7817589576547235,31.502471241712353,"['SLC7A5', 'HSP90AA1', 'JUN', 'CDKN1B', 'TGFB1', 'AIP', 'BAX', 'JUNB']",0.11036711453891031,0,0,8
7,Peptide GPCRs WP24,0.002108527747081669,6.269512195121951,38.631262850030296,"['OPRD1', 'MC1R', 'OPRK1', 'NMBR', 'ACKR1', 'HCRTR2']",0.130457783183401,0,0,6
8,Senescence and Autophagy in Cancer WP615,0.002169776019682345,2.5331271265078876,15.536001351307192,"['JUN', 'CEBPB', 'TGFB1', 'CDKN1B', 'PCNA', 'GSN', 'IGFBP5', 'CDKN2A', 'FN1', 'PLAT', 'CXCL14', 'RSL1D1', 'MAP1LC3A', 'IGFBP7', 'IL6ST', 'SLC39A3']",0.130457783183401,0,0,16
9,Mevalonate pathway WP3963,0.003527755903484742,11.133116883116884,62.86975011041556,"['HMGCS1', 'MVD', 'HMGCR', 'ACAT2']",0.181401065448303,0,0,4
10,Vitamin D Receptor Pathway WP2877,0.0037713319220021415,2.551341350601295,14.237319139673462,"['ABCB1', 'TGFB1', 'CDKN1B', 'IGFBP5', 'GADD45A', 'CDKN2A', 'PTHLH', 'ADAMTS5', 'SFRP1', 'CCNE1', 'PNOC', 'TIMP2', 'TIMP3', 'JUNB']",0.181401065448303,0,0,14
11,ACE Inhibitor Pathway WP554,0.004526890349574453,25.034063260340634,135.12686474906192,"['TGFB1', 'ATP6AP2', 'AGT']",0.19704421414072096,0,0,3
12,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.005528963370843078,2.989396411092985,15.538149953104154,"['BEX3', 'CDKN1B', 'HSPA5', 'RIPK2', 'F2R', 'HSPB1', 'PTK2B', 'APOE', 'VIM', 'ETS1']",0.19704421414072096,0,0,10
13,Nanomaterial induced apoptosis WP2507,0.00583815394088956,5.966693744922827,30.68873841351438,"['ENDOG', 'CASP6', 'HTRA2', 'BAX', 'CYCS']",0.19704421414072096,0,0,5
14,Statin inhibition of cholesterol production WP430,0.00583815394088956,5.966693744922827,30.68873841351438,"['SQLE', 'HMGCR', 'APOE', 'LDLR', 'FDFT1']",0.19704421414072096,0,0,5
15,Photodynamic therapy-induced unfolded protein response WP3613,0.006413408238536131,3.901545972335232,19.70032750495351,"['PPP1R15A', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'BBC3']",0.19704421414072096,0,0,7
16,Monoamine GPCRs WP58,0.006554485293662236,4.558314855875832,22.917409688115715,"['HRH1', 'CHRM5', 'HTR2C', 'ADRA1D', 'HTR4', 'HTR5A']",0.19704421414072096,0,0,6
17,Nuclear Receptors Meta-Pathway WP2882,0.010108444971665857,1.7051540454938094,7.834132581284579,"['ABCB1', 'CDKN1B', 'SRXN1', 'SLC7A11', 'SLC5A3', 'SLC5A4', 'DNAJB1', 'RGS2', 'SLC39A6', 'SLC39A7', 'JUNB', 'CBR3', 'SLC39A3', 'JUN', 'HSP90AA1', 'TGFB1', 'PLK2', 'SLC2A12', 'SLC39A11', 'AIP', 'SLC39A13', 'SLC2A9', 'TGFBR3', 'SLC7A5', 'FASN', 'B3GNT5', 'BAX', 'FKBP5']",0.22752624781044056,0,0,28
18,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.010647502403004888,6.678571428571429,30.336942749989365,"['SFRP1', 'SST', 'SMAD9', 'DCN']",0.22752624781044056,0,0,4
19,Composition of Lipid Particles WP3601,0.01149110381714684,inf,inf,"['APOE', 'LDLR']",0.22752624781044056,0,0,2
20,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.01149110381714684,inf,inf,"['TGFB1', 'VIP']",0.22752624781044056,0,0,2
21,COVID-19 adverse outcome pathway WP4891,0.01149110381714684,inf,inf,"['IL7', 'AGT']",0.22752624781044056,0,0,2
22,Gastric acid production WP2596,0.01149110381714684,inf,inf,"['CCK', 'VIP']",0.22752624781044056,0,0,2
23,Endochondral Ossification with Skeletal Dysplasias WP4808,0.011605095819406306,2.6147022838499185,11.65192650363233,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'PLAT', 'SOX6', 'GLI3', 'RUNX2', 'PTHLH', 'VEGFA']",0.22752624781044056,0,0,10
24,Endochondral Ossification WP474,0.011605095819406306,2.6147022838499185,11.65192650363233,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'PLAT', 'SOX6', 'GLI3', 'RUNX2', 'PTHLH', 'VEGFA']",0.22752624781044056,0,0,10
25,Unfolded protein response WP4925,0.01192137303149336,3.856285178236398,17.081116091074126,"['PPP1R15A', 'XBP1', 'HSPA5', 'DDIT3', 'TXNIP', 'BBC3']",0.22752624781044056,0,0,6
26,Imatinib and Chronic Myeloid Leukemia WP3640,0.012298716097861652,4.6398591930679665,20.407308970582136,"['SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'PIM1']",0.22752624781044056,0,0,5
27,NRF2 pathway WP2884,0.013887149908960252,2.0600555846457484,8.810427870755627,"['HSP90AA1', 'TGFB1', 'SRXN1', 'SLC2A12', 'SLC39A11', 'SLC39A13', 'SLC7A11', 'SLC5A3', 'SLC5A4', 'SLC2A9', 'DNAJB1', 'SLC39A6', 'SLC39A7', 'SLC39A3', 'CBR3']",0.24320700926955252,0,0,15
28,Selenium Micronutrient Network WP15,0.014157580581179774,2.6882640586797066,11.445297854559524,"['RFK', 'SELENOW', 'PNPO', 'PLAT', 'SELENOT', 'KMO', 'SEPHS2', 'LDLR', 'SELENOH']",0.24320700926955252,0,0,9
29,Cardiac Progenitor Differentiation WP2406,0.01551801923567222,3.580487804878049,14.915429243032303,"['MESP1', 'LIN28B', 'TGFB1', 'TNNT2', 'ROR2', 'THY1']",0.24880557507861129,0,0,6
30,Genes controlling nephrogenesis WP4823,0.01551801923567222,3.580487804878049,14.915429243032303,"['ILK', 'CD36', 'ETV4', 'GLI3', 'FGFR2', 'VEGFA']",0.24880557507861129,0,0,6
31,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.016258095869141845,5.564935064935065,22.922881778613153,"['IDI1', 'HMGCS1', 'MVD', 'HMGCR']",0.2522627133244267,0,0,4
32,Development of ureteric collection system WP5053,0.01692046236974235,3.0789687807802664,12.559826740924388,"['SALL1', 'FRAS1', 'ILK', 'ETV4', 'GLI3', 'FGFR2', 'FREM2']",0.2543356999951897,0,0,7
33,Biogenic Amine Synthesis WP550,0.019176404377227025,8.343065693430656,32.98910493210174,"['GAD1', 'PAH', 'GAD2']",0.27576242824249464,0,0,3
34,IL-18 signaling pathway WP4754,0.01949256249531147,1.6520153188943867,6.505177555642183,"['CEBPB', 'STOML1', 'CD81', 'RGS16', 'COX17', 'HSPB1', 'PLD1', 'ACACB', 'CENPB', 'ADAMTS5', 'TIMP3', 'CD36', 'JUN', 'TICAM2', 'PRKCD', 'FN1', 'BPGM', 'RUNX2', 'VEGFA', 'ARL4D', 'SYT10', 'CYCS', 'BAX', 'ITM2C', 'ARF6']",0.27576242824249464,0,0,25
35,Proximal tubule transport WP4917,0.020784957220192277,2.9247355573637104,11.329038535755082,"['ATP6V1G1', 'ABCB1', 'CA4', 'SLC3A1', 'ATP1B1', 'ATP6V0C', 'ATP6V1D']",0.28564469779749957,0,0,7
36,Zinc homeostasis WP3529,0.02239036210379314,3.7955099327966915,14.419615443442193,"['SLC39A6', 'SLC39A11', 'SLC39A13', 'SLC39A7', 'SLC39A3']",0.2991601158867917,0,0,5
37,TP53 network WP1742,0.023415765657132052,4.76948051948052,17.906278858172804,"['CDKN2A', 'GADD45A', 'BAX', 'BBC3']",0.3044049535427167,0,0,4
38,Apoptosis Modulation and Signaling WP1772,0.029627133923543835,2.0910204081632653,7.358436002775041,"['HRK', 'JUN', 'ENDOG', 'CASP6', 'CDKN2A', 'HTRA2', 'CYCS', 'BAX', 'PTPN13', 'BCL2L2', 'BBC3']",0.35205468794900036,0,0,11
39,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.030912917116331838,6.25669099756691,21.75189400087024,"['NSDHL', 'CYP51A1', 'SC5D']",0.35205468794900036,0,0,3
40,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.03201245685526035,16.67585089141005,57.39211162508022,"['BAX', 'IL6ST']",0.35205468794900036,0,0,2
41,miR-517 relationship with ARCN1 and USP1 WP3596,0.03201245685526035,16.67585089141005,57.39211162508022,"['USP1', 'ARCN1']",0.35205468794900036,0,0,2
42,miRNA targets in ECM and membrane receptors WP2911,0.0322045868394096,4.1728896103896105,14.336573118074208,"['COL5A1', 'COL5A3', 'COL5A2', 'FN1']",0.35205468794900036,0,0,4
43,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.0322045868394096,4.1728896103896105,14.336573118074208,"['DDR1', 'TGFB1', 'FN1', 'IGFBP7']",0.35205468794900036,0,0,4
44,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.0322045868394096,4.1728896103896105,14.336573118074208,"['TGFB1', 'FN1', 'VIM', 'RUNX2']",0.35205468794900036,0,0,4
45,White fat cell differentiation WP4149,0.03669428959693746,3.2109604449165783,10.612654965698502,"['WNT10B', 'TLE3', 'CEBPB', 'DDIT3', 'NR2F2']",0.38797857810895536,0,0,5
46,Oncostatin M Signaling Pathway WP2374,0.03710398044285228,2.0901305057096247,6.884954733275056,"['CEBPB', 'CDKN1B', 'PRKCH', 'PRKCD', 'TIMP3', 'PTK2B', 'IL6ST', 'JUNB', 'LDLR', 'VEGFA']",0.38797857810895536,0,0,10
47,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.042669148419102854,3.7088744588744587,11.69882533609382,"['BAX', 'PTHLH', 'BCL2L14', 'BCL2L2']",0.436677880629542,0,0,4
48,Galanin receptor pathway WP4970,0.04558525298334136,5.004866180048662,15.455882667450505,"['CDKN1B', 'PRKCD', 'VEGFA']",0.44747972826504473,0,0,3
49,miR-509-3p alteration of YAP1/ECM axis WP3967,0.04558525298334136,5.004866180048662,15.455882667450505,"['COL5A1', 'PBX3', 'FN1']",0.44747972826504473,0,0,3
50,G1 to S cell cycle control WP45,0.05171052092496195,2.1559314910160765,6.38607177416925,"['CDKN1B', 'PCNA', 'CDK6', 'CCNE1', 'CDKN2A', 'GADD45A', 'RPA3', 'POLE2']",0.4974552112981339,0,0,8
51,Cytokines and Inflammatory Response WP530,0.0594980776442739,8.33711507293355,23.525765317545396,"['TGFB1', 'IL7']",0.53997311975275,0,0,2
52,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.0594980776442739,8.33711507293355,23.525765317545396,"['FN1', 'VIM']",0.53997311975275,0,0,2
53,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.0594980776442739,8.33711507293355,23.525765317545396,"['APOE', 'LDLR']",0.53997311975275,0,0,2
54,Development and heterogeneity of the ILC family WP3893,0.06305415094833554,4.170316301703163,11.525759149209462,"['NFIL3', 'IL7', 'TOX']",0.5514372110208982,0,0,3
55,miRNAs involved in DNA damage response WP1545,0.06305415094833554,4.170316301703163,11.525759149209462,"['CDKN1B', 'CDK6', 'CCNE1']",0.5514372110208982,0,0,3
56,DNA damage response WP707,0.06651786745651168,2.0248741486526503,5.487985391822603,"['CDKN1B', 'CDK6', 'CCNE1', 'GADD45A', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.5691060895751562,0,0,8
57,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.0686240191171706,3.033943329397875,8.128276021828544,"['HMGCS1', 'FASN', 'HMGCR', 'LDLR']",0.5691060895751562,0,0,4
58,Striated Muscle Contraction Pathway WP383,0.0686240191171706,3.033943329397875,8.128276021828544,"['MYOM1', 'TNNT2', 'VIM', 'ACTG1']",0.5691060895751562,0,0,4
59,miRNA regulation of DNA damage response WP1530,0.08369076521713023,1.9087947882736156,4.735007201144897,"['CDKN1B', 'CDK6', 'CCNE1', 'GADD45A', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.6822925096515193,0,0,8
60,Adipogenesis WP236,0.08707994760947076,1.644005143040823,4.012899244947157,"['LIPE', 'SFRP4', 'WNT10B', 'CEBPB', 'TGFB1', 'WNT5B', 'GADD45A', 'DDIT3', 'NDN', 'IL6ST', 'RXRG', 'AGT']",0.6939045412112634,0,0,12
61,Dopaminergic Neurogenesis WP2855,0.09222067057425751,5.5575364667747165,13.246782646762297,"['TGFB1', 'ASCL1']",0.6939045412112634,0,0,2
62,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.09222067057425751,5.5575364667747165,13.246782646762297,"['CEBPB', 'ALDH1L1']",0.6939045412112634,0,0,2
63,NAD Biosynthesis II (from tryptophan) WP2485,0.09222067057425751,5.5575364667747165,13.246782646762297,"['NMNAT1', 'KMO']",0.6939045412112634,0,0,2
64,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.09316693612728527,1.8555917480998914,4.403991652804992,"['SFRP4', 'WNT10B', 'SFRP1', 'JUN', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4']",0.6939045412112634,0,0,8
65,Ferroptosis WP4313,0.09521351293127522,2.0865853658536584,4.906883848104426,"['PRNP', 'MAP1LC3A', 'PCBP1', 'VDAC3', 'SAT2', 'SLC7A11']",0.6939045412112634,0,0,6
66,Parkinson's disease pathway WP2371,0.09521351293127522,2.0865853658536584,4.906883848104426,"['PINK1', 'CASP6', 'CCNE1', 'HTRA2', 'CYCS', 'UBE2L6']",0.6939045412112634,0,0,6
67,BMP Signaling Pathway in Eyelid Development WP3927,0.10549483662994787,3.1271289537712894,7.033204681722166,"['JUN', 'SFRP1', 'FGFR2']",0.7091754866027827,0,0,3
68,NOTCH1 regulation of endothelial cell calcification WP3413,0.10549483662994787,3.1271289537712894,7.033204681722166,"['PLAT', 'SOX6', 'VEGFA']",0.7091754866027827,0,0,3
69,The influence of laminopathies on Wnt signaling WP4844,0.10703468971670839,2.1956902817563813,4.906494540751952,"['WNT10B', 'CEBPB', 'CDK6', 'TCF7', 'RUNX2']",0.7091754866027827,0,0,5
70,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.10723555977903823,inf,inf,['FMO5'],0.7091754866027827,0,0,1
71,Codeine and Morphine Metabolism WP1604,0.10723555977903823,inf,inf,['ABCB1'],0.7091754866027827,0,0,1
72,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.10723555977903823,inf,inf,['AGT'],0.7091754866027827,0,0,1
73,Fas ligand pathway and stress induction of heat shock proteins WP314,0.10791563440297432,2.0029268292682927,4.459327348959384,"['JUN', 'CASP6', 'RIPK2', 'HSPB1', 'CYCS', 'ACTG1']",0.7091754866027827,0,0,6
74,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.10910392101581273,1.7080462324961103,3.7840986217024306,"['SFRP4', 'WNT10B', 'SFRP1', 'JUN', 'CDK6', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4']",0.7091754866027827,0,0,9
75,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.113873581090366,1.757586147779873,3.8186483397696116,"['CDKN1B', 'TRPC6', 'INF2', 'PCNA', 'TGFB1', 'FAT1', 'ILK', 'VIM']",0.7266731763134873,0,0,8
76,Eukaryotic Transcription Initiation WP405,0.1181675885772642,1.8258238405207485,3.8993232775434103,"['GTF2A2', 'POLR2E', 'ILK', 'TAF7', 'POLR2I', 'GTF2H4', 'POLR2K']",0.7266731763134873,0,0,7
77,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.11933793902172556,2.383116883116883,5.0660203063009845,"['LDHA', 'PDHB', 'ACACB', 'VEGFA']",0.7266731763134873,0,0,4
78,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.1214399303617447,1.925703564727955,4.060029262656885,"['HSP90AA1', 'JUN', 'CCNE1', 'CDKN2A', 'BAX', 'JUNB']",0.7266731763134873,0,0,6
79,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.12283234205356364,1.6059104028108921,3.367489611959772,"['IDI1', 'SQLE', 'HMGCS1', 'INSIG1', 'FASN', 'CYP51A1', 'MVD', 'HMGCR', 'LDLR', 'FDFT1']",0.7266731763134873,0,0,10
80,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.1287428325247243,4.167747163695299,8.543624996939917,"['TCF7', 'VEGFA']",0.7266731763134873,0,0,2
81,Aspirin and miRNAs WP4707,0.1287428325247243,4.167747163695299,8.543624996939917,"['MVD', 'VEGFA']",0.7266731763134873,0,0,2
82,IL1 and megakaryocytes in obesity WP2865,0.1287428325247243,4.167747163695299,8.543624996939917,"['F2R', 'TIMP2']",0.7266731763134873,0,0,2
83,Sulfation Biotransformation Reaction WP692,0.1287428325247243,4.167747163695299,8.543624996939917,"['SULT4A1', 'PAPSS2']",0.7266731763134873,0,0,2
84,Transcriptional cascade regulating adipogenesis WP4211,0.1287428325247243,4.167747163695299,8.543624996939917,"['CEBPB', 'DDIT3']",0.7266731763134873,0,0,2
85,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.12974296167822724,1.6334644413734454,3.3358610881545587,"['PSMD8', 'TUBB2B', 'TUBA1A', 'TUBB2A', 'HSPA5', 'CCNE1', 'TUBB', 'UBE2L6', 'TUBA8']",0.7266731763134873,0,0,9
86,Phytochemical activity on NRF2 transcriptional activation WP3,0.12992493381072745,2.7793998377939984,5.672194818446908,"['AIMP2', 'CEBPB', 'SLC7A11']",0.7266731763134873,0,0,3
87,Prader-Willi and Angelman Syndrome WP3998,0.1357534487948122,1.85420054200542,3.702680717739421,"['CDK6', 'DLX5', 'CDKN2A', 'HTR2C', 'NDN', 'GABRD']",0.7505449295437318,0,0,6
88,Angiogenesis WP1539,0.13901692561134507,2.2240259740259742,4.388358170776946,"['TIMP2', 'TIMP3', 'FGFR2', 'VEGFA']",0.7513161934725503,0,0,4
89,DNA Mismatch Repair WP531,0.13901692561134507,2.2240259740259742,4.388358170776946,"['PCNA', 'RPA3', 'POLE2', 'POLE3']",0.7513161934725503,0,0,4
90,Folate Metabolism WP176,0.15988373927821556,2.0848214285714284,3.822120548650415,"['AHCY', 'RFK', 'PLAT', 'LDLR']",0.8450997647562822,0,0,4
91,NRF2-ARE regulation WP4357,0.15988373927821556,2.0848214285714284,3.822120548650415,"['AIMP2', 'CEBPB', 'PGAM5', 'SLC7A11']",0.8450997647562822,0,0,4
92,Apoptosis WP254,0.1619575548265569,1.5895765472312704,2.8936985043572774,"['HRK', 'JUN', 'CASP6', 'CDKN2A', 'CYCS', 'BAX', 'BCL2L2', 'BBC3']",0.8467563464301509,0,0,8
93,Cancer immunotherapy by PD-1 blockade WP4585,0.16787481790506217,3.3338735818476497,5.949419789455148,"['JUN', 'HLA-A']",0.8499767096035253,0,0,2
94,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.16787481790506217,3.3338735818476497,5.949419789455148,"['GALNT3', 'FGFR2']",0.8499767096035253,0,0,2
95,Osteoclast Signaling WP12,0.16787481790506217,3.3338735818476497,5.949419789455148,"['AIMP2', 'ATP6V1G1']",0.8499767096035253,0,0,2
96,DNA Replication WP466,0.17497813514057844,1.8131247130293504,3.1604472707319773,"['PCNA', 'DBF4', 'RPA3', 'POLE2', 'GMNN']",0.8749661030093951,0,0,5
97,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.18180434064972645,1.9619938884644768,3.344854703612213,"['RAB3B', 'RAB3A', 'HSPB1', 'RAB11A']",0.8749661030093951,0,0,4
98,Lung fibrosis WP3624,0.18180434064972645,1.9619938884644768,3.344854703612213,"['CEBPB', 'TGFB1', 'FAM13A', 'FGF1']",0.8749661030093951,0,0,4
99,IL-6 signaling pathway WP364,0.18301867250875783,1.6682926829268292,2.8330397402752228,"['PRKCD', 'GAB1', 'VIP', 'IL6ST', 'JUNB', 'AGT']",0.8749661030093951,0,0,6
100,Pathogenic Escherichia coli infection WP2272,0.18301867250875783,1.6682926829268292,2.8330397402752228,"['TUBB2B', 'TUBA1A', 'TUBB2A', 'TUBB', 'ACTG1', 'TUBA8']",0.8749661030093951,0,0,6
101,Vitamin B12 metabolism WP1533,0.18372469106850087,2.2736120327361204,3.852219259407756,"['PLAT', 'APOE', 'LDLR']",0.8749661030093951,0,0,3
102,Cell cycle WP179,0.18746189163315674,1.4125588697017268,2.3648773830877086,"['TGFB1', 'CDK6', 'CDKN1B', 'DBF4', 'PCNA', 'CCNE1', 'GADD45A', 'CDKN2A', 'BUB3', 'CDC14B', 'GADD45G']",0.8840114693681215,0,0,11
103,Drug Induction of Bile Acid Pathway WP2289,0.20298005748413606,8.331174089068826,13.285286297774887,['ABCB1'],0.9120708214274638,0,0,1
104,EV release from cardiac cells and their functional effects WP3297,0.20298005748413606,8.331174089068826,13.285286297774887,['RGS16'],0.9120708214274638,0,0,1
105,Oxysterols derived from cholesterol WP4545,0.20463981137002085,1.852813852813853,2.939496334755267,"['DBP', 'INSIG1', 'EPHX2', 'ACOT2']",0.9120708214274638,0,0,4
106,Leptin and adiponectin WP3934,0.2086380173865771,2.7779578606158832,4.353489169979691,"['LEPR', 'ADIPOR1']",0.9120708214274638,0,0,2
107,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.2086380173865771,2.7779578606158832,4.353489169979691,"['SFRP1', 'TGFB1']",0.9120708214274638,0,0,2
108,Matrix Metalloproteinases WP129,0.2086380173865771,2.7779578606158832,4.353489169979691,"['TIMP2', 'TIMP3']",0.9120708214274638,0,0,2
109,Serotonin and anxiety-related events WP3944,0.2086380173865771,2.7779578606158832,4.353489169979691,"['CRH', 'HTR2C']",0.9120708214274638,0,0,2
110,Gastric Cancer Network 1 WP2361,0.21249986398375437,2.0839416058394162,3.2276377898775808,"['SMOC2', 'GATD3B', 'KIF15']",0.9120708214274638,0,0,3
111,One-carbon metabolism WP241,0.21249986398375437,2.0839416058394162,3.2276377898775808,"['ALDH1L1', 'AHCY', 'CHDH']",0.9120708214274638,0,0,3
112,Type II interferon signaling (IFNG) WP619,0.21249986398375437,2.0839416058394162,3.2276377898775808,"['PRKCD', 'HLA-B', 'IFIT2']",0.9120708214274638,0,0,3
113,Glucocorticoid Receptor Pathway WP2880,0.2176468980412363,1.563719512195122,2.38448658494614,"['TGFBR3', 'RGS2', 'HSP90AA1', 'JUN', 'B3GNT5', 'PLK2']",0.9120708214274638,0,0,6
114,Acute viral myocarditis WP4298,0.21858891526556581,1.4970895662514865,2.276418122390587,"['ENDOG', 'CXADR', 'TGFB1', 'CASP6', 'ILK', 'CYCS', 'BAX']",0.9120708214274638,0,0,7
115,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.235734045779946,1.5161862527716186,2.1909665124176563,"['WNT10B', 'CEBPB', 'TGFB1', 'TCF7', 'JUNB', 'RUNX2']",0.9120708214274638,0,0,6
116,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.24214554624279103,1.9234512446191279,2.727869912869644,"['FGF1', 'RUNX2', 'FGFR2']",0.9120708214274638,0,0,3
117,Methionine De Novo and Salvage Pathway WP3580,0.24214554624279103,1.9234512446191279,2.727869912869644,"['AHCY', 'CHDH', 'SRM']",0.9120708214274638,0,0,3
118,Nucleotide metabolism WP404,0.24214554624279103,1.9234512446191279,2.727869912869644,"['PRPS1', 'OAZ1', 'SRM']",0.9120708214274638,0,0,3
119,Ovarian infertility WP34,0.24214554624279103,1.9234512446191279,2.727869912869644,"['CEBPB', 'CDKN1B', 'SMPD1']",0.9120708214274638,0,0,3
120,Small cell lung cancer WP4658,0.24418612765944622,1.3649699933318515,1.9243681741406313,"['CDKN1B', 'CDK6', 'CCNE1', 'GADD45A', 'FN1', 'CYCS', 'BAX', 'RXRG', 'GADD45G']",0.9120708214274638,0,0,9
121,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.24820603655761944,1.3900651465798046,1.9370503398808143,"['JUN', 'TGFB1', 'GADD45A', 'TCF7', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.9120708214274638,0,0,8
122,Spinal Cord Injury WP2431,0.24820603655761944,1.3900651465798046,1.9370503398808143,"['TGFB1', 'CDKN1B', 'GADD45A', 'APEX1', 'AQP4', 'VIM', 'GFAP', 'TNFSF13B']",0.9120708214274638,0,0,8
123,Alanine and aspartate metabolism WP106,0.2502334123167636,2.380875202593193,3.298372002557414,"['GAD1', 'GAD2']",0.9120708214274638,0,0,2
124,Hypertrophy Model WP516,0.2502334123167636,2.380875202593193,3.298372002557414,"['WDR1', 'VEGFA']",0.9120708214274638,0,0,2
125,Major receptors targeted by epinephrine and norepinephrine WP4589,0.2502334123167636,2.380875202593193,3.298372002557414,"['ADCY10', 'ADRA1D']",0.9120708214274638,0,0,2
126,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.25249213418635036,1.6672077922077921,2.2947034292473734,"['LDHA', 'ANGPT2', 'BAX', 'VEGFA']",0.9120708214274638,0,0,4
127,Exercise-induced Circadian Regulation WP410,0.25425952870151164,1.4714490674318508,2.015002010197051,"['PER2', 'DNAJA1', 'IDI1', 'CEBPB', 'RBPMS', 'HERPUD1']",0.9120708214274638,0,0,6
128,Aryl Hydrocarbon Receptor Netpath WP2586,0.25508714730728377,1.543911905406625,2.109215308335862,"['HSP90AA1', 'CDKN1B', 'AIP', 'CD36', 'VEGFA']",0.9120708214274638,0,0,5
129,Nephrotic syndrome WP4758,0.25508714730728377,1.543911905406625,2.109215308335862,"['ANLN', 'TRPC6', 'INF2', 'GPC5', 'WDR73']",0.9120708214274638,0,0,5
130,7-oxo-C and 7beta-HC pathways WP5064,0.2723968752931457,1.7858880778588808,2.322538829767542,"['DBP', 'EPHX2', 'ACOT2']",0.9120708214274638,0,0,3
131,Differentiation Pathway WP2848,0.2723968752931457,1.7858880778588808,2.322538829767542,"['TGFB1', 'FGF1', 'VEGFA']",0.9120708214274638,0,0,3
132,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.2723968752931457,1.7858880778588808,2.322538829767542,"['TICAM2', 'PLAT', 'TIRAP']",0.9120708214274638,0,0,3
133,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.2723968752931457,1.7858880778588808,2.322538829767542,"['TGFBR3', 'ANGPT2', 'RUNX2']",0.9120708214274638,0,0,3
134,Sleep regulation WP3591,0.2723968752931457,1.7858880778588808,2.322538829767542,"['AHCY', 'CRH', 'HCRTR2']",0.9120708214274638,0,0,3
135,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.2731642687042742,1.4292682926829268,1.8547356621072102,"['PPP1R15A', 'PPP1R14A', 'XBP1', 'MAP1LC3A', 'HSPA5', 'DDIT3']",0.9120708214274638,0,0,6
136,TGF-beta Receptor Signaling WP560,0.2763967352446689,1.4886271324126725,1.9142524231662092,"['TGFBR3', 'JUN', 'TGFB1', 'SMAD9', 'RUNX2']",0.9120708214274638,0,0,5
137,Bladder cancer WP2828,0.2772306569817718,1.5876623376623376,2.0368206222594862,"['RPS6KA5', 'CDKN2A', 'DAPK2', 'VEGFA']",0.9120708214274638,0,0,4
138,Oxidative Damage WP3941,0.2772306569817718,1.5876623376623376,2.0368206222594862,"['PCNA', 'CDKN1B', 'GADD45A', 'CYCS']",0.9120708214274638,0,0,4
139,Retinoblastoma gene in cancer WP2446,0.2798088160719418,1.3342019543973942,1.6993045964564675,"['ANLN', 'CDKN1B', 'PCNA', 'CDK6', 'H2AFZ', 'CCNE1', 'RPA3', 'POLE2']",0.9120708214274638,0,0,8
140,T-cell receptor (TCR) signaling pathway WP69,0.2798088160719418,1.3342019543973942,1.6993045964564675,"['JUN', 'TGFB1', 'RIPK2', 'PRKCD', 'PTK2B', 'LCP2', 'CD247', 'VIM']",0.9120708214274638,0,0,8
141,Endometrial cancer WP4155,0.28618689687764604,1.3572955891535943,1.6981263505824562,"['GADD45A', 'TCF7', 'ILK', 'BAX', 'FGF1', 'FGFR2', 'GADD45G']",0.9120708214274638,0,0,7
142,Osteoblast differentiation WP4787,0.28842331223272644,1.2939887024702807,1.6088498542337106,"['WNT10B', 'PRKCH', 'WNT5B', 'PRKCD', 'SMAD9', 'FGF1', 'RUNX2', 'FGFR2', 'GLI3']",0.9120708214274638,0,0,9
143,Pyrimidine metabolism WP4022,0.28842331223272644,1.2939887024702807,1.6088498542337106,"['NT5C', 'NME6', 'POLE2', 'POLR1C', 'TWISTNB', 'POLE3', 'POLR2E', 'POLR2I', 'POLR2K']",0.9120708214274638,0,0,9
144,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.2884638632205709,4.1651821862348175,5.178093925293285,['EPHX2'],0.9120708214274638,0,0,1
145,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.2884638632205709,4.1651821862348175,5.178093925293285,['ABCB1'],0.9120708214274638,0,0,1
146,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.2884638632205709,4.1651821862348175,5.178093925293285,['CD247'],0.9120708214274638,0,0,1
147,Platelet-mediated interactions with vascular and circulating cells WP4462,0.2884638632205709,4.1651821862348175,5.178093925293285,['TGFB1'],0.9120708214274638,0,0,1
148,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.2884638632205709,4.1651821862348175,5.178093925293285,['VEGFA'],0.9120708214274638,0,0,1
149,Tgif disruption of Shh signaling WP3674,0.2884638632205709,4.1651821862348175,5.178093925293285,['GLI3'],0.9120708214274638,0,0,1
150,Vitamin B6-dependent and responsive disorders WP4228,0.2884638632205709,4.1651821862348175,5.178093925293285,['PNPO'],0.9120708214274638,0,0,1
151,Differentiation of white and brown adipocyte WP2895,0.29201435862750397,2.083063209076175,2.5641514577168127,"['CEBPB', 'SMAD9']",0.9120708214274638,0,0,2
152,Glycolysis in senescence WP5049,0.29201435862750397,2.083063209076175,2.5641514577168127,"['LDHA', 'ALDOC']",0.9120708214274638,0,0,2
153,"GPCRs, Class B Secretin-like WP334",0.29201435862750397,2.083063209076175,2.5641514577168127,"['VIPR2', 'ADGRG2']",0.9120708214274638,0,0,2
154,Kynurenine Pathway and links to Cellular Senescence WP5044,0.29201435862750397,2.083063209076175,2.5641514577168127,"['KMO', 'ACMSD']",0.9120708214274638,0,0,2
155,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.29709369710542183,1.2183431789576193,1.4787125115090527,"['DLX2', 'JUN', 'CEBPB', 'VIPR2', 'SLC1A3', 'ATP1A3', 'AQP4', 'ASCL1', 'VEGFA', 'PRKAR1A', 'SST', 'PAH', 'TAC1']",0.9219488277916638,0,0,13
156,Base Excision Repair WP4752,0.30233123147742846,1.5153482880755609,1.812708218921013,"['PCNA', 'APEX1', 'POLE2', 'POLE3']",0.9249632856383053,0,0,4
157,Glioblastoma signaling pathways WP2261,0.303625432067461,1.2719323691517135,1.5160931028008717,"['CDKN1B', 'PRKCH', 'CDK6', 'CCNE1', 'CDKN2A', 'PRKCD', 'GAB1', 'SPRY2', 'FGFR2']",0.9249632856383053,0,0,9
158,AMP-activated protein kinase (AMPK) signaling WP1403,0.30383409382713567,1.3263185146830387,1.5800080600253414,"['LIPE', 'STRADB', 'FASN', 'LEPR', 'HMGCR', 'ADIPOR1', 'ACACB']",0.9249632856383053,0,0,7
159,DNA damage response (only ATM dependent) WP710,0.30969594845879944,1.2445521170655693,1.4588195290495867,"['WNT10B', 'JUN', 'TGFB1', 'CDKN1B', 'WNT5B', 'CDKN2A', 'TCF7', 'BAX', 'LDLR', 'BBC3']",0.936878938419387,0,0,10
160,Breast cancer pathway WP4262,0.32842247126049234,1.2068098818474757,1.343727866134145,"['SFRP4', 'WNT10B', 'JUN', 'SHC3', 'CDK6', 'WNT5B', 'GADD45A', 'TCF7', 'BAX', 'FGF1', 'GADD45G']",0.9382992468657463,0,0,11
161,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.3315612698323279,1.3160462130937098,1.4528395576844393,"['IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'ETS1', 'RXRG']",0.9382992468657463,0,0,6
162,Cori Cycle WP1946,0.3334631357591433,1.851431658562939,2.0332847511022076,"['LDHA', 'PGAM1']",0.9382992468657463,0,0,2
163,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.3334631357591433,1.851431658562939,2.0332847511022076,"['IL6ST', 'SOX4']",0.9382992468657463,0,0,2
164,Overview of nanoparticle effects WP3287,0.3334631357591433,1.851431658562939,2.0332847511022076,"['FN1', 'BAX']",0.9382992468657463,0,0,2
165,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.3334631357591433,1.851431658562939,2.0332847511022076,"['BCL2L2', 'VEGFA']",0.9382992468657463,0,0,2
166,Serotonin and anxiety WP3947,0.3334631357591433,1.851431658562939,2.0332847511022076,"['CRH', 'HTR2C']",0.9382992468657463,0,0,2
167,Tryptophan catabolism leading to NAD+ production WP4210,0.3334631357591433,1.851431658562939,2.0332847511022076,"['NMNAT1', 'KMO']",0.9382992468657463,0,0,2
168,TYROBP causal network in microglia WP3945,0.3334631357591433,1.851431658562939,2.0332847511022076,"['LOXL3', 'LHFPL2']",0.9382992468657463,0,0,2
169,IL-7 signaling pathway WP205,0.3337571054042343,1.5623479318734794,1.7144296603751226,"['CDKN1B', 'IL7', 'PTK2B']",0.9382992468657463,0,0,3
170,Pancreatic adenocarcinoma pathway WP4263,0.3345474954064088,1.2299891779229628,1.346809146971779,"['TGFB1', 'CDK6', 'CDKN2A', 'GADD45A', 'PRKCD', 'BAX', 'PLD1', 'VEGFA', 'GADD45G']",0.9382992468657463,0,0,9
171,GABA receptor Signaling WP4159,0.35311399065856,1.3887987012987013,1.4456899435772255,"['SLC32A1', 'GAD1', 'GAD2', 'GABRD']",0.9382992468657463,0,0,4
172,"GPCRs, Other WP117",0.35311399065856,1.3887987012987013,1.4456899435772255,"['ADGRV1', 'F2R', 'ADRA1D', 'ACKR1']",0.9382992468657463,0,0,4
173,Tumor suppressor activity of SMARCB1 WP4204,0.35311399065856,1.3887987012987013,1.4456899435772255,"['CDK6', 'H3F3B', 'CDKN2A', 'GLI3']",0.9382992468657463,0,0,4
174,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.36423107742502664,1.3020410235580828,1.3150181860750083,"['TGFBR3', 'JUN', 'TGFB1', 'SMAD9', 'RUNX2']",0.9382992468657463,0,0,5
175,Cell migration and invasion through p75NTR WP4561,0.364440633896599,1.4703019894089022,1.4841104934024296,"['JUN', 'EFNA3', 'EFNB3']",0.9382992468657463,0,0,3
176,Physiological and pathological hypertrophy of the heart WP1528,0.364440633896599,1.4703019894089022,1.4841104934024296,"['JUN', 'IL6ST', 'AGT']",0.9382992468657463,0,0,3
177,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.36478577788751465,2.776518218623482,2.799965936069908,['APOE'],0.9382992468657463,0,0,1
178,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.36478577788751465,2.776518218623482,2.799965936069908,['EPHX2'],0.9382992468657463,0,0,1
179,Bile acids synthesis and enterohepatic circulation  WP4389,0.36478577788751465,2.776518218623482,2.799965936069908,['LDLR'],0.9382992468657463,0,0,1
180,Blood Clotting Cascade WP272,0.36478577788751465,2.776518218623482,2.799965936069908,['PLAT'],0.9382992468657463,0,0,1
181,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.36478577788751465,2.776518218623482,2.799965936069908,['RUNX2'],0.9382992468657463,0,0,1
182,FOXP3 in COVID-19 WP5063,0.36478577788751465,2.776518218623482,2.799965936069908,['IL6ST'],0.9382992468657463,0,0,1
183,Metastatic brain tumor WP2249,0.36478577788751465,2.776518218623482,2.799965936069908,['CDK6'],0.9382992468657463,0,0,1
184,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.36478577788751465,2.776518218623482,2.799965936069908,['VEGFA'],0.9382992468657463,0,0,1
185,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.36478577788751465,2.776518218623482,2.799965936069908,['STRADB'],0.9382992468657463,0,0,1
186,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.36478577788751465,2.776518218623482,2.799965936069908,['VEGFA'],0.9382992468657463,0,0,1
187,Role of Osx and miRNAs in tooth development WP3971,0.36478577788751465,2.776518218623482,2.799965936069908,['RUNX2'],0.9382992468657463,0,0,1
188,Airway smooth muscle cell contraction WP4962,0.37417076682018463,1.66612641815235,1.6378738958182135,"['PPP1R14A', 'MYLK']",0.947242836002678,0,0,2
189,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.37417076682018463,1.66612641815235,1.6378738958182135,"['CD81', 'HSPB1']",0.947242836002678,0,0,2
190,GDNF/RET signaling axis WP4830,0.37417076682018463,1.66612641815235,1.6378738958182135,"['SALL1', 'GLI3']",0.947242836002678,0,0,2
191,Mitochondrial CIV Assembly WP4922,0.3785617889963027,1.3331168831168831,1.2949577086738575,"['COX17', 'COX14', 'COX7C', 'COX20']",0.953341468624197,0,0,4
192,VEGFA-VEGFR2 Signaling Pathway WP3888,0.38848309105353124,1.063562313027305,1.005604158857605,"['SET', 'TRAF3IP2', 'HSPB1', 'SHB', 'RPL10A', 'ETS1', 'ACACB', 'APOLD1', 'HERPUD1', 'ACTG1', 'LDHA', 'RPS6KA5', 'RPL18A', 'RPLP2', 'DNAJB9', 'PTK2B', 'IGFBP7', 'MYH11', 'IER5', 'TXNDC5', 'JUN', 'HSP90AA1', 'SSR4', 'TRPC3', 'PRKCD', 'FN1', 'GAB1', 'RAB11A', 'VEGFA', 'DNAJA1', 'RCN1', 'KATNAL2', 'TXNIP', 'PTPN9', 'CYCS', 'RPL26', 'CALR', 'ARF6']",0.9732310770663987,0,0,38
193,Head and Neck Squamous Cell Carcinoma WP4674,0.39436621411645434,1.1903986981285597,1.107636614244594,"['CDK6', 'MAML1', 'CDKN2A', 'GAB1', 'FAT1', 'FGFR2', 'VEGFA']",0.9776427310891307,0,0,7
194,Wnt signaling pathway and pluripotency WP399,0.3963837410473176,1.1695525458597633,1.082271756106987,"['WNT10B', 'JUN', 'PRKCH', 'WNT5B', 'PRKCD', 'TCF7', 'ZBTB33', 'LDLR']",0.9776427310891307,0,0,8
195,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.4039042793346615,1.2817182817182817,1.1619767779416685,"['IFITM3', 'JUN', 'DDIT3', 'JUNB']",0.9776427310891307,0,0,4
196,Neural Crest Differentiation WP2064,0.41120728673507956,1.1902439024390243,1.0577195805790436,"['DLX5', 'LHX2', 'ASCL1', 'ETS1', 'FGFR2', 'GFAP']",0.9776427310891307,0,0,6
197,Non-small cell lung cancer WP4255,0.41263610484693686,1.1664768104149714,1.0325526472003346,"['CDK6', 'CDKN2A', 'GADD45A', 'CYCS', 'BAX', 'RXRG', 'GADD45G']",0.9776427310891307,0,0,7
198,Apoptosis Modulation by HSP70 WP384,0.41381967913474443,1.5145130396345956,1.3362926536092041,"['CASP6', 'CYCS']",0.9776427310891307,0,0,2
199,Globo Sphingolipid Metabolism WP1424,0.41381967913474443,1.5145130396345956,1.3362926536092041,"['B3GALNT1', 'ST6GAL1']",0.9776427310891307,0,0,2
200,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.41381967913474443,1.5145130396345956,1.3362926536092041,"['FGFR2', 'GADD45G']",0.9776427310891307,0,0,2
201,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.41381967913474443,1.5145130396345956,1.3362926536092041,"['ASCL1', 'SOX6']",0.9776427310891307,0,0,2
202,Omega-9 FA synthesis WP4724,0.41381967913474443,1.5145130396345956,1.3362926536092041,"['FASN', 'ACOT2']",0.9776427310891307,0,0,2
203,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.42904493892051815,1.2341269841269842,1.0443103713669726,"['MAP1LC3A', 'IGFBP5', 'ILK', 'PLD1']",0.9776427310891307,0,0,4
204,Integrated Cancer Pathway WP1971,0.42904493892051815,1.2341269841269842,1.0443103713669726,"['CDKN1B', 'BAX', 'BACH1', 'BBC3']",0.9776427310891307,0,0,4
205,p38 MAPK Signaling Pathway WP400,0.42904493892051815,1.2341269841269842,1.0443103713669726,"['RPS6KA5', 'DDIT3', 'HSPB1', 'HMGN1']",0.9776427310891307,0,0,4
206,Nucleotide Excision Repair WP4753,0.4306526847874111,1.190089358245329,1.0025947660564485,"['PCNA', 'RPA3', 'POLE2', 'POLE3', 'GTF2H4']",0.9776427310891307,0,0,5
207,Farnesoid X receptor pathway WP2879,0.4329270306070371,2.0821862348178137,1.743177343664794,['FKBP5'],0.9776427310891307,0,0,1
208,Inflammatory Response Pathway WP453,0.4329270306070371,2.0821862348178137,1.743177343664794,['FN1'],0.9776427310891307,0,0,1
209,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.4329270306070371,2.0821862348178137,1.743177343664794,['ACOT2'],0.9776427310891307,0,0,1
210,Liver X receptor pathway WP2874,0.4329270306070371,2.0821862348178137,1.743177343664794,['FASN'],0.9776427310891307,0,0,1
211,miRNA Biogenesis WP2338,0.4329270306070371,2.0821862348178137,1.743177343664794,['RAN'],0.9776427310891307,0,0,1
212,Mitochondrial fatty acid synthesis pathway WP4317,0.4329270306070371,2.0821862348178137,1.743177343664794,['HSD17B12'],0.9776427310891307,0,0,1
213,Peroxiredoxin 2 induced ovarian failure WP4873,0.4329270306070371,2.0821862348178137,1.743177343664794,['BAX'],0.9776427310891307,0,0,1
214,Wnt signaling WP428,0.44716834753522394,1.1107491856677525,0.8939533138486743,"['SFRP4', 'WNT10B', 'SFRP1', 'JUN', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4']",0.9893865391448681,0,0,8
215,Complement and Coagulation Cascades WP558,0.4521688286772421,1.3881685575364668,1.1017889039721274,"['F2R', 'PLAT']",0.9893865391448681,0,0,2
216,miRNA regulation of p53 pathway in prostate cancer WP3982,0.4521688286772421,1.3881685575364668,1.1017889039721274,"['BAX', 'BBC3']",0.9893865391448681,0,0,2
217,Pregnane X receptor pathway WP2876,0.4521688286772421,1.3881685575364668,1.1017889039721274,"['HSP90AA1', 'ABCB1']",0.9893865391448681,0,0,2
218,Transcription co-factors SKI and SKIL protein partners WP4533,0.4521688286772421,1.3881685575364668,1.1017889039721274,"['SATB2', 'MERTK']",0.9893865391448681,0,0,2
219,Triacylglyceride synthesis WP325,0.4521688286772421,1.3881685575364668,1.1017889039721274,"['LIPE', 'AGPAT1']",0.9893865391448681,0,0,2
220,p53 transcriptional gene network WP4963,0.45252606780014754,1.1569184944489574,0.917332138273496,"['GADD45A', 'BAX', 'SLC7A11', 'BBC3', 'RPRM']",0.9893865391448681,0,0,5
221,Phosphodiesterases in neuronal function WP4222,0.4741662243951611,1.1255406503172547,0.8398754330081074,"['ADCY10', 'PDE10A', 'PDE1A', 'PDE5A', 'PDE6B']",0.9895850300768441,0,0,5
222,One-carbon metabolism and related pathways WP3940,0.4783786951257144,1.1487908643081057,0.8470639432186838,"['CHDH', 'GAD1', 'GAD2', 'PLD1']",0.9895850300768441,0,0,4
223,Lipid Metabolism Pathway WP3965,0.48326478635744896,1.1897810218978102,0.865197531901387,"['LIPE', 'PRKAR1A', 'FASN']",0.9895850300768441,0,0,3
224,Signal transduction through IL1R WP4496,0.48326478635744896,1.1897810218978102,0.865197531901387,"['JUN', 'TGFB1', 'IRAK3']",0.9895850300768441,0,0,3
225,Canonical and non-canonical Notch signaling WP3845,0.48904095969179645,1.2812616880688195,0.9164980563759428,"['MAML1', 'PSEN2']",0.9895850300768441,0,0,2
226,Constitutive Androstane Receptor Pathway WP2875,0.48904095969179645,1.2812616880688195,0.9164980563759428,"['HSP90AA1', 'ABCB1']",0.9895850300768441,0,0,2
227,Hematopoietic Stem Cell Differentiation WP2849,0.48904095969179645,1.2812616880688195,0.9164980563759428,"['PIM1', 'RUNX1']",0.9895850300768441,0,0,2
228,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.48904095969179645,1.2812616880688195,0.9164980563759428,"['JUN', 'MYLK']",0.9895850300768441,0,0,2
229,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.48904095969179645,1.2812616880688195,0.9164980563759428,"['EIF1AX', 'EIF3I']",0.9895850300768441,0,0,2
230,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.48904095969179645,1.2812616880688195,0.9164980563759428,"['JUN', 'SRXN1']",0.9895850300768441,0,0,2
231,Toll-like Receptor Signaling related to MyD88 WP3858,0.48904095969179645,1.2812616880688195,0.9164980563759428,"['TICAM2', 'TIRAP']",0.9895850300768441,0,0,2
232,Vitamin A and carotenoid metabolism WP716,0.48904095969179645,1.2812616880688195,0.9164980563759428,"['CD36', 'RXRG']",0.9895850300768441,0,0,2
233,Cellular Proteostasis WP4918,0.4937638403709824,1.665587044534413,1.1754013329415072,['VBP1'],0.9895850300768441,0,0,1
234,"Degradation pathway of sphingolipids, including diseases WP4153",0.4937638403709824,1.665587044534413,1.1754013329415072,['NEU1'],0.9895850300768441,0,0,1
235,Disorders of Folate Metabolism and Transport WP4259,0.4937638403709824,1.665587044534413,1.1754013329415072,['ALDH1L1'],0.9895850300768441,0,0,1
236,Eicosanoid Synthesis WP167,0.4937638403709824,1.665587044534413,1.1754013329415072,['PTGES2'],0.9895850300768441,0,0,1
237,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.4937638403709824,1.665587044534413,1.1754013329415072,['AHCY'],0.9895850300768441,0,0,1
238,Methylation Pathways WP704,0.4937638403709824,1.665587044534413,1.1754013329415072,['NNMT'],0.9895850300768441,0,0,1
239,Selective expression of chemokine receptors during T-cell polarization WP4494,0.4937638403709824,1.665587044534413,1.1754013329415072,['TGFB1'],0.9895850300768441,0,0,1
240,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.4937638403709824,1.665587044534413,1.1754013329415072,['JUN'],0.9895850300768441,0,0,1
241,Genotoxicity pathway WP4286,0.5024227342738967,1.1103896103896105,0.7642960630539827,"['RPS27', 'GADD45A', 'BLOC1S2', 'PCDH8']",0.9997197228527197,0,0,4
242,Nuclear receptors WP170,0.5113603352886429,1.1355894713558947,0.7616180325952978,"['NR2E1', 'NR2F2', 'RXRG']",0.9997197228527197,0,0,3
243,ESC Pluripotency Pathways WP3931,0.5136522282933744,1.0409201954397393,0.6934702371586888,"['WNT10B', 'JUN', 'WNT5B', 'GAB1', 'SMAD9', 'FGF1', 'IL6ST', 'FGFR2']",0.9997197228527197,0,0,8
244,Ebola Virus Pathway on Host WP4217,0.5232496199656717,1.0265934286766922,0.6649211184572646,"['GSN', 'VPS4A', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'MERTK', 'ASGR1', 'ACTG1']",0.9997197228527197,0,0,9
245,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5243117137889096,1.1896272285251215,0.768105301536188,"['H3F3B', 'H2AFZ']",0.9997197228527197,0,0,2
246,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5243117137889096,1.1896272285251215,0.768105301536188,"['BAX', 'BBC3']",0.9997197228527197,0,0,2
247,Pre-implantation embryo WP3527,0.5243117137889096,1.1896272285251215,0.768105301536188,"['DLX2', 'DDIT3']",0.9997197228527197,0,0,2
248,Proteoglycan biosynthesis WP4784,0.5243117137889096,1.1896272285251215,0.768105301536188,"['B4GALT7', 'PAPSS2']",0.9997197228527197,0,0,2
249,Melanoma WP4685,0.527895149024487,1.0408536585365853,0.6649572664851594,"['CDK6', 'CDKN2A', 'GADD45A', 'BAX', 'ETS1', 'GADD45G']",0.9997197228527197,0,0,6
250,Proteasome Degradation WP183,0.527895149024487,1.0408536585365853,0.6649572664851594,"['PSMD8', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F']",0.9997197228527197,0,0,6
251,Complement system WP2806,0.5386249857122191,1.0861102295567544,0.6720151835587851,"['PRNP', 'CALR', 'DCN']",0.9997197228527197,0,0,3
252,Dual hijack model of Vif in HIV infection WP3300,0.5480786441440245,1.3878542510121457,0.8345674054884352,['RUNX1'],0.9997197228527197,0,0,1
253,HIF1A and PPARG regulation of glycolysis WP2456,0.5480786441440245,1.3878542510121457,0.8345674054884352,['LDHA'],0.9997197228527197,0,0,1
254,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.5480786441440245,1.3878542510121457,0.8345674054884352,['TGFB1'],0.9997197228527197,0,0,1
255,Neuroinflammation WP4919,0.5480786441440245,1.3878542510121457,0.8345674054884352,['JUN'],0.9997197228527197,0,0,1
256,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5480786441440245,1.3878542510121457,0.8345674054884352,['BUB3'],0.9997197228527197,0,0,1
257,Metabolic reprogramming in colon cancer WP4290,0.5489566655789686,1.0407873376623376,0.6241973994803265,"['LDHA', 'PGAM1', 'FASN', 'PDHB']",0.9997197228527197,0,0,4
258,Nonalcoholic fatty liver disease WP4396,0.5533339303157494,0.9928435866083551,0.5875584877191511,"['XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'NDUFB11', 'ADIPOR1', 'COX7A1', 'COX7C', 'BBC3', 'DDIT3', 'LEPR', 'CYCS', 'BAX']",0.9997197228527197,0,0,13
259,Pathways in clear cell renal cell carcinoma WP4018,0.554534320503026,1.004797845178306,0.5924555166440398,"['LDHA', 'TGFB1', 'FASN', 'ALDOC', 'ACACB', 'KCNJ2', 'VEGFA']",0.9997197228527197,0,0,7
260,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5574123995916067,1.0153355392205425,0.5934127734233487,"['JUN', 'CDKN1B', 'FN1', 'MYLK', 'PFN2']",0.9997197228527197,0,0,5
261,NAD+ biosynthetic pathways WP3645,0.5579003379988116,1.1102106969205834,0.6478911389439133,"['NMNAT1', 'ACMSD']",0.9997197228527197,0,0,2
262,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5579003379988116,1.1102106969205834,0.6478911389439133,"['RPS6KA5', 'HTR4']",0.9997197228527197,0,0,2
263,TLR4 Signaling and Tolerance WP3851,0.5579003379988116,1.1102106969205834,0.6478911389439133,"['IRAK3', 'TIRAP']",0.9997197228527197,0,0,2
264,BDNF-TrkB Signaling WP3676,0.564994840680635,1.0407542579075426,0.594206861606403,"['TRPC6', 'TRPC3', 'GAB1']",0.9997197228527197,0,0,3
265,Glycolysis and Gluconeogenesis WP534,0.564994840680635,1.0407542579075426,0.594206861606403,"['LDHA', 'PGAM1', 'ALDOC']",0.9997197228527197,0,0,3
266,PPAR signaling pathway WP3942,0.5713476322993373,1.0091499409681228,0.5648791889896467,"['ILK', 'SLC27A6', 'CD36', 'RXRG']",0.9997197228527197,0,0,4
267,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5897617754574427,1.0407212317666126,0.5495388945574846,"['B3GALNT1', 'B3GALT1']",0.9997197228527197,0,0,2
268,Oxidation by Cytochrome P450 WP43,0.5897617754574427,1.0407212317666126,0.5495388945574846,"['CYB5R1', 'CYP51A1']",0.9997197228527197,0,0,2
269,Wnt signaling in kidney disease WP4150,0.5897617754574427,1.0407212317666126,0.5495388945574846,"['WNT10B', 'WNT5B']",0.9997197228527197,0,0,2
270,ATM Signaling Pathway WP2516,0.590420525470178,0.9990267639902677,0.5264074231846708,"['JUN', 'GADD45A', 'CCNE1']",0.9997197228527197,0,0,3
271,Androgen receptor signaling pathway WP138,0.5925595679148117,0.9650191191049426,0.5049982439567792,"['JUN', 'KAT5', 'CCNE1', 'CALR', 'FKBP4', 'ETV5', 'RUNX2', 'RAN']",0.9997197228527197,0,0,8
272,3q29 copy number variation syndrome WP4906,0.5964918085645043,0.9679217123533523,0.50011524696986,"['JUN', 'TGFB1', 'NCBP2', 'WDR34', 'DYNLL2']",0.9997197228527197,0,0,5
273,Estrogen Receptor Pathway WP2881,0.5965701266496293,1.1894736842105262,0.6144327192882292,['JUN'],0.9997197228527197,0,0,1
274,ID signaling pathway WP53,0.5965701266496293,1.1894736842105262,0.6144327192882292,['CCNE1'],0.9997197228527197,0,0,1
275,Mitochondrial CII Assembly WP4920,0.5965701266496293,1.1894736842105262,0.6144327192882292,['SDHAF1'],0.9997197228527197,0,0,1
276,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5965701266496293,1.1894736842105262,0.6144327192882292,['RNASEH2C'],0.9997197228527197,0,0,1
277,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.5965701266496293,1.1894736842105262,0.6144327192882292,['TGFB1'],0.9997197228527197,0,0,1
278,Trans-sulfuration pathway WP2333,0.5965701266496293,1.1894736842105262,0.6144327192882292,['AHCY'],0.9997197228527197,0,0,1
279,ATM Signaling Network in Development and Disease  WP3878,0.6141868131897673,0.9512987012987013,0.4637163939704803,"['KAT5', 'HSPB1', 'HMGN1', 'CDK5R1']",0.9997197228527197,0,0,4
280,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6148657462060084,0.9605090772973984,0.4671448709265953,"['JUN', 'TGFB1', 'VEGFA']",0.9997197228527197,0,0,3
281,Type 2 papillary renal cell carcinoma WP4241,0.6148657462060084,0.9605090772973984,0.4671448709265953,"['TGFB1', 'COL21A1', 'VEGFA']",0.9997197228527197,0,0,3
282,Myometrial relaxation and contraction pathways WP289,0.6183652916218609,0.9435977277508941,0.4535646958761815,"['RGS2', 'JUN', 'PRKCH', 'IGFBP5', 'PRKAR1A', 'RGS16', 'PRKCD', 'CRH', 'ATF5', 'CORIN', 'ACTG1']",0.9997197228527197,0,0,11
283,Fatty Acid Biosynthesis WP357,0.6198799484467369,0.9794069978072266,0.46838127109170896,"['FASN', 'ACACB']",0.9997197228527197,0,0,2
284,Glycerolipids and Glycerophospholipids WP4722,0.6198799484467369,0.9794069978072266,0.46838127109170896,"['PLD1', 'CDIPT']",0.9997197228527197,0,0,2
285,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6198799484467369,0.9794069978072266,0.46838127109170896,"['HSP90AA1', 'RIPK2']",0.9997197228527197,0,0,2
286,PKC-gamma calcium signaling pathway in ataxia WP4760,0.6198799484467369,0.9794069978072266,0.46838127109170896,"['GNA14', 'TRPC3']",0.9997197228527197,0,0,2
287,Copper homeostasis WP3286,0.6383058903666647,0.9248445525817789,0.41519754796096664,"['PRNP', 'JUN', 'COX17']",0.9997197228527197,0,0,3
288,15q11.2 copy number variation syndrome WP4940,0.6398621787891416,1.0406882591093118,0.4646698797123243,['TUBGCP4'],0.9997197228527197,0,0,1
289,Biomarkers for pyrimidine metabolism disorders WP4584,0.6398621787891416,1.0406882591093118,0.4646698797123243,['NT5C'],0.9997197228527197,0,0,1
290,Biotin Metabolism (including IEMs) WP5031,0.6398621787891416,1.0406882591093118,0.4646698797123243,['ACACB'],0.9997197228527197,0,0,1
291,Genes targeted by miRNAs in adipocytes WP1992,0.6398621787891416,1.0406882591093118,0.4646698797123243,['KCNJ2'],0.9997197228527197,0,0,1
292,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.6398621787891416,1.0406882591093118,0.4646698797123243,['SOX4'],0.9997197228527197,0,0,1
293,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.6398621787891416,1.0406882591093118,0.4646698797123243,['JUN'],0.9997197228527197,0,0,1
294,Purine metabolism WP4792,0.6398621787891416,1.0406882591093118,0.4646698797123243,['PRPS1'],0.9997197228527197,0,0,1
295,Pyrimidine metabolism and related diseases WP4225,0.6398621787891416,1.0406882591093118,0.4646698797123243,['NT5C'],0.9997197228527197,0,0,1
296,RAS and bradykinin pathways in COVID-19 WP4969,0.6398621787891416,1.0406882591093118,0.4646698797123243,['AGT'],0.9997197228527197,0,0,1
297,Endothelin Pathways WP2197,0.6482620699348957,0.9249054565099946,0.4009097369730763,"['ADCY10', 'MYLK']",0.9997197228527197,0,0,2
298,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6482620699348957,0.9249054565099946,0.4009097369730763,"['TGFBR3', 'TGFB1']",0.9997197228527197,0,0,2
299,Glycosylation and related congenital defects WP4521,0.6482620699348957,0.9249054565099946,0.4009097369730763,"['MPI', 'MAGT1']",0.9997197228527197,0,0,2
300,Sphingolipid Metabolism (general overview) WP4725,0.6482620699348957,0.9249054565099946,0.4009097369730763,"['CERS4', 'SMPD1']",0.9997197228527197,0,0,2
301,Pathways Regulating Hippo Signaling WP4540,0.6501825516535598,0.9100640764849471,0.3917845022727752,"['PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD', 'TCF7', 'FGFR2', 'CDH18']",0.9997197228527197,0,0,7
302,MECP2 and Associated Rett Syndrome WP3584,0.6501879462477759,0.907760532150776,0.39078528988455374,"['DLX5', 'SST', 'GAD1', 'OPRK1', 'SGK1', 'FKBP5']",0.9997197228527197,0,0,6
303,Modulators of TCR signaling and T cell activation WP5072,0.6542609122543506,0.8997016497016497,0.3816975779810576,"['CDKN1B', 'LCP2', 'CD247', 'ZFP36L1']",0.9997197228527197,0,0,4
304,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6542609122543506,0.8997016497016497,0.3816975779810576,"['EIF4A2', 'RPS6KA5', 'PRKCD', 'PIM1']",0.9997197228527197,0,0,4
305,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6607266870628262,0.8917274939172749,0.3695452571127231,"['JUN', 'GAB1', 'PTK2B']",0.9997197228527197,0,0,3
306,Target Of Rapamycin (TOR) Signaling WP1471,0.6607266870628262,0.8917274939172749,0.3695452571127231,"['IDI1', 'RRAGA', 'HMGCR']",0.9997197228527197,0,0,3
307,Metapathway biotransformation Phase I and II WP702,0.66488580595317,0.8959754647305501,0.3656834023807841,"['NNMT', 'EPHX2', 'CYP51A1', 'KCNAB1', 'SULT4A1', 'GAL3ST3', 'FMO5']",0.9997197228527197,0,0,7
308,Hepatitis B infection WP4666,0.6658328855319235,0.9041421377402653,0.36772958232089376,"['JUN', 'TICAM2', 'TGFB1', 'PCNA', 'ATP6AP1', 'VDAC3', 'CYCS', 'PTK2B', 'BAX', 'TIRAP']",0.9997197228527197,0,0,10
309,DNA IR-damage and cellular response via ATR WP4016,0.6659909063886535,0.8914634146341464,0.3623613914207649,"['SEM1', 'BRIP1', 'PCNA', 'POLN', 'ABRAXAS1', 'USP1']",0.9997197228527197,0,0,6
310,Sphingolipid Metabolism (integrated pathway) WP4726,0.6749338405098985,0.8761409195598396,0.3444465729093825,"['CERS4', 'SMPD1']",0.9997197228527197,0,0,2
311,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.6785118982478152,0.924966261808367,0.35875118350575247,['RUNX2'],0.9997197228527197,0,0,1
312,Canonical and non-canonical TGF-B signaling WP3874,0.6785118982478152,0.924966261808367,0.35875118350575247,['TGFB1'],0.9997197228527197,0,0,1
313,Computational Model of Aerobic Glycolysis WP4629,0.6785118982478152,0.924966261808367,0.35875118350575247,['LDHA'],0.9997197228527197,0,0,1
314,Cysteine and methionine catabolism WP4504,0.6785118982478152,0.924966261808367,0.35875118350575247,['AHCY'],0.9997197228527197,0,0,1
315,Fatty acid transporters WP5061,0.6785118982478152,0.924966261808367,0.35875118350575247,['CD36'],0.9997197228527197,0,0,1
316,Ganglio Sphingolipid Metabolism WP1423,0.6785118982478152,0.924966261808367,0.35875118350575247,['B3GALT1'],0.9997197228527197,0,0,1
317,Hedgehog Signaling Pathway Netpath WP47,0.6785118982478152,0.924966261808367,0.35875118350575247,['GLI3'],0.9997197228527197,0,0,1
318,Mammalian disorder of sexual development WP4842,0.6785118982478152,0.924966261808367,0.35875118350575247,['FGFR2'],0.9997197228527197,0,0,1
319,RalA downstream regulated genes WP2290,0.6785118982478152,0.924966261808367,0.35875118350575247,['EXOC8'],0.9997197228527197,0,0,1
320,DNA IR-double strand breaks and cellular response via ATM WP3959,0.6914436274854735,0.8533966033966034,0.31488086244767255,"['PCNA', 'KAT5', 'CDKN2A', 'BAX']",0.9997197228527197,0,0,4
321,Ethanol effects on histone modifications WP3996,0.6999354060072258,0.8322528363047001,0.29692053518067113,"['AHCY', 'HAT1']",0.9997197228527197,0,0,2
322,MTHFR deficiency WP4288,0.6999354060072258,0.8322528363047001,0.29692053518067113,"['CHDH', 'CYCS']",0.9997197228527197,0,0,2
323,Ectoderm Differentiation WP2858,0.7013846492213789,0.8753327037005237,0.31047948361150157,"['MAFB', 'PIM1', 'SPRY2', 'ROR2', 'NR2F2', 'ARHGAP15', 'JAKMIP1', 'PTPN13', 'FGFR2', 'GLI3']",0.9997197228527197,0,0,10
324,IL-3 signaling pathway WP286,0.7024973443346069,0.8321167883211679,0.2938318030805181,"['JUN', 'TGFB1', 'IL3RA']",0.9997197228527197,0,0,3
325,Integrated breast cancer pathway WP1984,0.7117553795516512,0.8710204081632653,0.29616522554291824,"['JUN', 'GADD45A', 'MAP3K7CL', 'BAX', 'FILIP1', 'HMGCR', 'FAU', 'JAKMIP1', 'BACH1', 'RPP38', 'VEGFA']",0.9997197228527197,0,0,11
326,Cell Differentiation - Index expanded WP2023,0.7130167353256651,0.8323886639676114,0.2815557878365744,['RUNX2'],0.9997197228527197,0,0,1
327,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7130167353256651,0.8323886639676114,0.2815557878365744,['CCK'],0.9997197228527197,0,0,1
328,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.7130167353256651,0.8323886639676114,0.2815557878365744,['RPH3AL'],0.9997197228527197,0,0,1
329,FOXA2 pathway WP5066,0.7130167353256651,0.8323886639676114,0.2815557878365744,['FASN'],0.9997197228527197,0,0,1
330,Leptin Insulin Overlap WP3935,0.7130167353256651,0.8323886639676114,0.2815557878365744,['LEPR'],0.9997197228527197,0,0,1
331,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.7130167353256651,0.8323886639676114,0.2815557878365744,['SFRP4'],0.9997197228527197,0,0,1
332,Riboflavin and CoQ disorders WP5037,0.7130167353256651,0.8323886639676114,0.2815557878365744,['RFK'],0.9997197228527197,0,0,1
333,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7165814364204062,0.8318440292445166,0.2772231524243872,"['JUN', 'CDKN1B', 'CCNE1', 'APEX1', 'PLD1']",0.9997197228527197,0,0,5
334,Cytosolic DNA-sensing pathway WP4655,0.7218593821479848,0.8051958245035712,0.26243338518946824,"['POLR1C', 'POLR2E', 'POLR2K']",0.9997197228527197,0,0,3
335,Glycogen Synthesis and Degradation WP500,0.7218593821479848,0.8051958245035712,0.26243338518946824,"['PHKG1', 'PPP2R5B', 'GYG1']",0.9997197228527197,0,0,3
336,IL17 signaling pathway WP2112,0.7233179686029035,0.7925445705024311,0.2567102292708764,"['CEBPB', 'TRAF3IP2']",0.9997197228527197,0,0,2
337,Neovascularisation processes WP4331,0.7233179686029035,0.7925445705024311,0.2567102292708764,"['TGFB1', 'SMAD9']",0.9997197228527197,0,0,2
338,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7233179686029035,0.7925445705024311,0.2567102292708764,"['TGFB1', 'BAX']",0.9997197228527197,0,0,2
339,Sphingolipid pathway WP1422,0.7233179686029035,0.7925445705024311,0.2567102292708764,"['CERS4', 'SERINC1']",0.9997197228527197,0,0,2
340,B Cell Receptor Signaling Pathway WP23,0.7245570245430951,0.8317073170731707,0.2679717822430939,"['JUN', 'CD81', 'PRKCD', 'GAB1', 'ETS1', 'ILF2']",0.9997197228527197,0,0,6
341,Corticotropin-releasing hormone signaling pathway WP2355,0.7245570245430951,0.8317073170731707,0.2679717822430939,"['CRHBP', 'HSP90AA1', 'TGFB1', 'PRKCD', 'CRH', 'JUNB']",0.9997197228527197,0,0,6
342,AGE/RAGE pathway WP2324,0.725689927318303,0.8116091225847324,0.26022822364626813,"['JUN', 'PRKCD', 'CYCS', 'TIRAP']",0.9997197228527197,0,0,4
343,TGF-beta Signaling Pathway WP366,0.7369437022671372,0.8407186615752315,0.2566241399963904,"['TGFBR3', 'JUN', 'TGFB1', 'FN1', 'STRAP', 'NEDD9', 'ETS1', 'JUNB', 'RUNX2']",0.9997197228527197,0,0,9
344,Interleukin-11 Signaling Pathway WP2332,0.7402243158970486,0.7799574209245742,0.23461275924825473,"['TGFB1', 'IL6ST', 'RUNX2']",0.9997197228527197,0,0,3
345,Synaptic Vesicle Pathway WP2267,0.7417163403570276,0.7922077922077922,0.23670249832927634,"['RAB3A', 'SLC32A1', 'SLC1A3', 'CPLX3']",0.9997197228527197,0,0,4
346,Translation Factors WP107,0.7417163403570276,0.7922077922077922,0.23670249832927634,"['EIF4A2', 'EEF1G', 'EIF1AX', 'EIF3I']",0.9997197228527197,0,0,4
347,ERK Pathway in Huntington's Disease WP3853,0.7438208744827297,0.7566433566433567,0.22393240976641385,['RPS6KA5'],0.9997197228527197,0,0,1
348,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.7438208744827297,0.7566433566433567,0.22393240976641385,['ABCB1'],0.9997197228527197,0,0,1
349,Omega-3/Omega-6 FA synthesis WP4723,0.7438208744827297,0.7566433566433567,0.22393240976641385,['ACOT2'],0.9997197228527197,0,0,1
350,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7438208744827297,0.7566433566433567,0.22393240976641385,['LDHA'],0.9997197228527197,0,0,1
351,Type II diabetes mellitus WP1584,0.7438208744827297,0.7566433566433567,0.22393240976641385,['PRKCD'],0.9997197228527197,0,0,1
352,Urea cycle and metabolism of amino groups WP497,0.7438208744827297,0.7566433566433567,0.22393240976641385,['SRM'],0.9997197228527197,0,0,1
353,Calcium Regulation in the Cardiac Cell WP536,0.7449437174523798,0.83963616590044,0.24722802310275532,"['GJD2', 'RGS2', 'PRKCH', 'PRKAR1A', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D', 'CALR', 'ATP1B1']",0.9997197228527197,0,0,10
354,Melatonin metabolism and effects WP3298,0.765469679424943,0.7234867169332676,0.19336316468347223,"['PER2', 'APOE']",0.9997197228527197,0,0,2
355,Heart Development WP1591,0.7713209337280608,0.6935222672064777,0.18007356681632203,['VEGFA'],0.9997197228527197,0,0,1
356,Kallmann's Syndrome WP5074,0.7713209337280608,0.6935222672064777,0.18007356681632203,['ASCL1'],0.9997197228527197,0,0,1
357,MAPK pathway in congenital thyroid cancer WP4928,0.7713209337280608,0.6935222672064777,0.18007356681632203,['JUN'],0.9997197228527197,0,0,1
358,NAD+ metabolism WP3644,0.7713209337280608,0.6935222672064777,0.18007356681632203,['NMNAT1'],0.9997197228527197,0,0,1
359,Nicotine Activity on Dopaminergic Neurons WP1602,0.7713209337280608,0.6935222672064777,0.18007356681632203,['CHRNA6'],0.9997197228527197,0,0,1
360,Rett syndrome causing genes WP4312,0.7716145137059948,0.7560507674144038,0.19602142478963946,"['KCNJ10', 'SATB2', 'IMPDH2', 'GABRD']",0.9997197228527197,0,0,4
361,Alzheimer's disease WP2059,0.7726917886363919,0.7699250834912899,0.19854445473040247,"['ATP5MD', 'PSEN2', 'CYCS', 'APOE', 'CDK5R1']",0.9997197228527197,0,0,5
362,Alpha 6 Beta 4 signaling pathway WP244,0.7843733754914032,0.6932739059967585,0.16837552211572215,"['PRKCD', 'GAB1']",0.9997197228527197,0,0,2
363,Intraflagellar transport proteins binding to dynein WP4532,0.7843733754914032,0.6932739059967585,0.16837552211572215,"['WDR34', 'DYNLL2']",0.9997197228527197,0,0,2
364,Purinergic signaling WP4900,0.7958710549347922,0.6401121146060418,0.1461491802240928,['P2RY14'],0.9997197228527197,0,0,1
365,Transcription factor regulation in adipogenesis WP3599,0.7958710549347922,0.6401121146060418,0.1461491802240928,['CEBPB'],0.9997197228527197,0,0,1
366,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7987230540486918,0.7230378317334839,0.162496251856,"['ANGPT2', 'FN1', 'BAX', 'ANGPTL1']",0.9997197228527197,0,0,4
367,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8019236295581464,0.6654781199351701,0.14689890502859182,"['PRKCH', 'PRKCD']",0.9997197228527197,0,0,2
368,miRNA regulation of prostate cancer signaling pathways WP3981,0.8019236295581464,0.6654781199351701,0.14689890502859182,"['CDKN1B', 'TCF7']",0.9997197228527197,0,0,2
369,Prion disease pathway WP3995,0.8019236295581464,0.6654781199351701,0.14689890502859182,"['PRNP', 'HSPA5']",0.9997197228527197,0,0,2
370,IL-4 signaling pathway WP395,0.8041711459616924,0.6930251419302514,0.15104009240279337,"['CEBPB', 'HRH1', 'NFIL3']",0.9997197228527197,0,0,3
371,PI3K-Akt signaling pathway WP4172,0.8059395063486557,0.8252522199674741,0.17804535519520456,"['HSP90AA1', 'CDKN1B', 'ANGPT2', 'F2R', 'FN1', 'PPP2R5B', 'FGF1', 'VEGFA', 'EFNA3', 'RELN', 'CDK6', 'CCNE1', 'IL7', 'IL3RA', 'COL6A6', 'SGK1', 'FGFR2']",0.9997197228527197,0,0,17
372,Ebstein-Barr virus LMP1 signaling WP262,0.8177874492648318,0.594331983805668,0.11955155344058663,['HSP90AA1'],0.9997197228527197,0,0,1
373,Mitochondrial complex III assembly WP4921,0.8177874492648318,0.594331983805668,0.11955155344058663,['UQCC3'],0.9997197228527197,0,0,1
374,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8198908124343308,0.7165466819798874,0.14229478021161393,"['TGFB1', 'IL6ST', 'AGT', 'FGFR2', 'MYLK']",0.9997197228527197,0,0,5
375,Gastrin signaling pathway WP4659,0.8289692343590531,0.7361856402756177,0.13808798686794518,"['JUN', 'PRKCH', 'CDKN1B', 'KAT5', 'CDKN2A', 'PRKCD', 'VEGFA']",0.9997197228527197,0,0,7
376,Endoderm differentiation WP2853,0.8300907806364656,0.7466969220071002,0.1390500575565227,"['DUSP4', 'SFRP1', 'TGFB1', 'TCF7', 'SLC2A12', 'PBX3', 'TOX', 'PTHLH']",0.9997197228527197,0,0,8
377,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8308423714686476,0.6564220770905366,0.12164498027932154,"['ADCY10', 'TGFB1', 'BANF1']",0.9997197228527197,0,0,3
378,Hedgehog Signaling Pathway WP4249,0.833254324159105,0.6160633891590132,0.11238004855592204,"['HHIP', 'GLI3']",0.9997197228527197,0,0,2
379,IL-5 signaling pathway WP127,0.833254324159105,0.6160633891590132,0.11238004855592204,"['SPRED1', 'JUN']",0.9997197228527197,0,0,2
380,Immune response to tuberculosis WP4197,0.8373524572442185,0.5546558704453441,0.09845707519136107,['IFIT3'],0.9997197228527197,0,0,1
381,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.8373524572442185,0.5546558704453441,0.09845707519136107,['CEBPB'],0.9997197228527197,0,0,1
382,Monoamine Transport WP727,0.8373524572442185,0.5546558704453441,0.09845707519136107,['AGT'],0.9997197228527197,0,0,1
383,"Relationship between inflammation, COX-2 and EGFR WP4483",0.8373524572442185,0.5546558704453441,0.09845707519136107,['PTGES2'],0.9997197228527197,0,0,1
384,G Protein Signaling Pathways WP35,0.8471587504167047,0.7020954998282377,0.11645459727022053,"['GNA14', 'PRKCH', 'PRKD3', 'PRKAR1A', 'PDE1A', 'PRKCD']",0.9997197228527197,0,0,6
385,IL-2 signaling pathway WP49,0.8471791829419146,0.5940032414910859,0.09851131319629898,"['JUN', 'PTK2B']",0.9997197228527197,0,0,2
386,Circadian rhythm related genes WP3594,0.8505872084517224,0.754656771799629,0.12212484853024061,"['PER2', 'JUN', 'AHCY', 'DBP', 'NFIL3', 'CRH', 'RBM4B', 'ATF5', 'RPS27A', 'HCRTR2', 'CIART']",0.9997197228527197,0,0,11
387,Insulin Signaling WP481,0.8505872084517224,0.754656771799629,0.12212484853024061,"['LIPE', 'XBP1', 'JUN', 'RPS6KA5', 'PRKCH', 'SHC3', 'PRKCD', 'GAB1', 'SGK1', 'GYG1', 'ARF6']",0.9997197228527197,0,0,11
388,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8548181734912108,0.5199392712550607,0.08156105122183857,['H3F3B'],0.9997197228527197,0,0,1
389,Oxidative Stress WP408,0.8548181734912108,0.5199392712550607,0.08156105122183857,['JUNB'],0.9997197228527197,0,0,1
390,Purine metabolism and related disorders WP4224,0.8548181734912108,0.5199392712550607,0.08156105122183857,['PRPS1'],0.9997197228527197,0,0,1
391,Netrin-UNC5B signaling pathway WP4747,0.8600379463393754,0.5734644833174984,0.086466267745917,"['JUN', 'PTK2B']",0.9997197228527197,0,0,2
392,Notch Signaling WP268,0.8600379463393754,0.5734644833174984,0.086466267745917,"['MAML1', 'PSEN2']",0.9997197228527197,0,0,2
393,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8600379463393754,0.5734644833174984,0.086466267745917,"['TGFB1', 'IFIT2']",0.9997197228527197,0,0,2
394,DNA Repair Pathways Full Network WP4946,0.8613083822772986,0.7143007250183881,0.10664700622223076,"['BRIP1', 'PCNA', 'RPA3', 'POLE2', 'APEX1', 'POLE3', 'USP1', 'GTF2H4']",0.9997197228527197,0,0,8
395,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8622778827462029,0.734599893170105,0.10885131560652563,"['LINGO1', 'JUN', 'RAB3A', 'RPS6KA5', 'SHC3', 'PRKCD', 'PTK2B', 'FRS3', 'ACACB', 'CDK5R1']",0.9997197228527197,0,0,10
396,Focal Adhesion WP306,0.8635030137009893,0.7422399203583873,0.10892956555189595,"['JUN', 'RELN', 'SHC3', 'COL5A3', 'COL5A2', 'FN1', 'TESK2', 'ILK', 'MYLK', 'VEGFA', 'ACTG1']",0.9997197228527197,0,0,11
397,16p11.2 distal deletion syndrome WP4950,0.8704096852119213,0.4893069778518695,0.06791153963114999,['CD81'],0.9997197228527197,0,0,1
398,1q21.1 copy number variation syndrome WP4905,0.8704096852119213,0.4893069778518695,0.06791153963114999,['FMO5'],0.9997197228527197,0,0,1
399,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8704096852119213,0.4893069778518695,0.06791153963114999,['SGK1'],0.9997197228527197,0,0,1
400,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.8704096852119213,0.4893069778518695,0.06791153963114999,['MAP1LC3A'],0.9997197228527197,0,0,1
401,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8704096852119213,0.4893069778518695,0.06791153963114999,['HTR2C'],0.9997197228527197,0,0,1
402,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.8704096852119213,0.4893069778518695,0.06791153963114999,['IDH3B'],0.9997197228527197,0,0,1
403,Trans-sulfuration and one-carbon metabolism WP2525,0.8704096852119213,0.4893069778518695,0.06791153963114999,['AHCY'],0.9997197228527197,0,0,1
404,Tryptophan metabolism WP465,0.8704096852119213,0.4893069778518695,0.06791153963114999,['ACMSD'],0.9997197228527197,0,0,1
405,Vitamin D in inflammatory diseases WP4482,0.8704096852119213,0.4893069778518695,0.06791153963114999,['DUSP1'],0.9997197228527197,0,0,1
406,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8730526444341121,0.7669477873590448,0.1041203883604635,"['HSP90AA1', 'CDKN1B', 'ANGPT2', 'F2R', 'FN1', 'PPP2R5B', 'FGF1', 'VEGFA', 'LIPE', 'EFNA3', 'RELN', 'COL5A1', 'COL5A3', 'COL5A2', 'IL3RA', 'FGFR2']",0.9997197228527197,0,0,16
407,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.87553941603998,0.6489896425670186,0.08626052784417645,"['SHC3', 'GAB1', 'BAX', 'FGFR2', 'VEGFA']",0.9997197228527197,0,0,5
408,Regulation of toll-like receptor signaling pathway WP1449,0.8832314706133574,0.6389426982440792,0.07933621881354576,"['JUN', 'CUEDC2', 'TICAM2', 'IRAK3', 'TIRAP']",0.9997197228527197,0,0,5
409,Gastric Cancer Network 2 WP2363,0.8843279629654422,0.4620782726045884,0.05680202811772498,['DSCC1'],0.9997197228527197,0,0,1
410,Estrogen signaling pathway WP712,0.8967524429147593,0.4377157468570211,0.047700265402366,['JUN'],0.9997197228527197,0,0,1
411,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8967524429147593,0.4377157468570211,0.047700265402366,['PTHLH'],0.9997197228527197,0,0,1
412,16p11.2 proximal deletion syndrome WP4949,0.8975841642852088,0.5933441558441559,0.06410987876958904,"['PCNA', 'KCTD13', 'SEZ6L2', 'CDIPT']",0.9997197228527197,0,0,4
413,Cannabinoid receptor signaling WP3869,0.907843332617093,0.41578947368421054,0.04019996346648695,['PRKAR1A'],0.9997197228527197,0,0,1
414,Nanoparticle triggered autophagic cell death WP2509,0.907843332617093,0.41578947368421054,0.04019996346648695,['MAP1LC3A'],0.9997197228527197,0,0,1
415,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9084987373536819,0.5418385697662118,0.051995794148238454,"['NDUFA7', 'NDUFB11', 'TMEM70']",0.9997197228527197,0,0,3
416,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9106425340059037,0.4888931261321384,0.045762766419678795,"['JUN', 'LCP2']",0.9997197228527197,0,0,2
417,Ciliopathies WP4803,0.9110002114292037,0.6910204081632653,0.06441149768825263,"['TMEM237', 'MAK', 'NME9', 'CCDC65', 'DNAAF4', 'CCNQ', 'WDR34', 'DNAI1', 'TRIM32', 'CCDC28B', 'GLI3']",0.9997197228527197,0,0,11
418,Oxidative phosphorylation WP623,0.9155056724977668,0.530258321685562,0.0468105252828317,"['NDUFA7', 'ATP6AP1', 'ATP6AP2']",0.9997197228527197,0,0,3
419,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9155056724977668,0.530258321685562,0.0468105252828317,"['F2R', 'IL3RA', 'IL6ST']",0.9997197228527197,0,0,3
420,Toll-like Receptor Signaling Pathway WP75,0.9155056724977668,0.530258321685562,0.0468105252828317,"['JUN', 'TICAM2', 'TIRAP']",0.9997197228527197,0,0,3
421,MAPK Signaling Pathway WP382,0.9188073126890571,0.7073769510199194,0.059899866193075184,"['DUSP4', 'JUN', 'TGFB1', 'GADD45A', 'DUSP1', 'RASGRF2', 'PRKCD', 'HSPB1', 'FGF1', 'DUSP7', 'CACNA1G', 'RPS6KA5', 'DDIT3', 'FGFR2']",0.9997197228527197,0,0,14
422,Regulation of Actin Cytoskeleton WP51,0.9193811355204246,0.6443186489990829,0.05415789094855468,"['GSN', 'CHRM5', 'F2R', 'FN1', 'FGF1', 'FGFR2', 'MYLK', 'ACTG1']",0.9997197228527197,0,0,8
423,RANKL/RANK signaling pathway WP2018,0.9256085239632235,0.4616423554835224,0.03568675172491018,"['JUN', 'PAPSS2']",0.9997197228527197,0,0,2
424,Hippo-Merlin Signaling Dysregulation WP4541,0.9264696165625327,0.5764283780124559,0.04402415683720398,"['PPP1R14A', 'LIN28B', 'PRKAR1A', 'FGFR2', 'CDH18']",0.9997197228527197,0,0,5
425,7q11.23 copy number variation syndrome WP4932,0.9313177736583121,0.5684764586092163,0.04044979168293183,"['PCNA', 'UBE2L6', 'GTF2IRD1', 'ACACB', 'USF1']",0.9997197228527197,0,0,5
426,Histone Modifications WP2369,0.9321726781094524,0.4491217311314556,0.03154505488238614,"['SET', 'H3F3B']",0.9997197228527197,0,0,2
427,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9344698277539564,0.3614504488646365,0.024497643810675235,['JUN'],0.9997197228527197,0,0,1
428,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.9344698277539564,0.3614504488646365,0.024497643810675235,['AGT'],0.9997197228527197,0,0,1
429,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9381858541426724,0.43726008700844493,0.02790034657151238,"['MAP1LC3A', 'GTPBP2']",0.9997197228527197,0,0,2
430,Regulation of Microtubule Cytoskeleton WP2038,0.9381858541426724,0.43726008700844493,0.02790034657151238,"['SPRED1', 'TESK2']",0.9997197228527197,0,0,2
431,Male infertility WP4673,0.9384836728918753,0.5270562770562771,0.03346270822978485,"['ABCB1', 'PEX10', 'TEX15', 'ETV5']",0.9997197228527197,0,0,4
432,TNF-alpha signaling pathway WP231,0.9384836728918753,0.5270562770562771,0.03346270822978485,"['HSP90AA1', 'JUN', 'RFK', 'BAX']",0.9997197228527197,0,0,4
433,MET in type 1 papillary renal cell carcinoma WP4205,0.9389006921884593,0.4884786031200801,0.030796409272298517,"['JUN', 'GAB1', 'ETS1']",0.9997197228527197,0,0,3
434,Glycerophospholipid Biosynthetic Pathway WP2533,0.9415114619995955,0.3463562753036437,0.020874462111810675,['CDIPT'],0.9997197228527197,0,0,1
435,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9415114619995955,0.3463562753036437,0.020874462111810675,['CDKN1B'],0.9997197228527197,0,0,1
436,Fatty acid beta-oxidation WP143,0.9477969474237076,0.33246963562753035,0.017825356239508223,['LIPE'],0.9997197228527197,0,0,1
437,Nanoparticle-mediated activation of receptor signaling WP2643,0.9477969474237076,0.33246963562753035,0.017825356239508223,['FN1'],0.9997197228527197,0,0,1
438,PDGFR-beta pathway WP3972,0.9477969474237076,0.33246963562753035,0.017825356239508223,['JUN'],0.9997197228527197,0,0,1
439,Wnt Signaling Pathway WP363,0.9533313775544433,0.4051468553583429,0.01936306833502188,"['CDK6', 'ROR2']",0.9997197228527197,0,0,2
440,Neural Crest Cell Migration during Development WP4564,0.9534074222678705,0.3196511990034257,0.015251502056021183,['JUN'],0.9997197228527197,0,0,1
441,Cardiac Hypertrophic Response WP2795,0.9575390181077048,0.39546191247974066,0.017158621298639,"['TGFB1', 'FGFR2']",0.9997197228527197,0,0,2
442,Notch Signaling Pathway Netpath WP61,0.9575390181077048,0.39546191247974066,0.017158621298639,"['MAML1', 'PSEN2']",0.9997197228527197,0,0,2
443,22q11.2 copy number variation syndrome WP4657,0.9579102262177376,0.48806340718105423,0.02098731949953833,"['RELN', 'DGCR6L', 'FGFR2', 'RAN']",0.9997197228527197,0,0,4
444,EGF/EGFR signaling pathway WP437,0.9580233978082288,0.596479217603912,0.025578864640982545,"['JUN', 'RPS6KA5', 'PCNA', 'PRKCD', 'GAB1', 'PTK2B', 'SPRY2', 'PLD1', 'ARF6']",0.9997197228527197,0,0,9
445,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9584153244853906,0.3077822762033288,0.013072763510814385,['SUPT4H1'],0.9997197228527197,0,0,1
446,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9584153244853906,0.3077822762033288,0.013072763510814385,['JUN'],0.9997197228527197,0,0,1
447,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.960883599806204,0.511929476186178,0.020427010664709932,"['NDUFA7', 'COX17', 'SLC25A5', 'COX7A1', 'COX7C']",0.9997197228527197,0,0,5
448,CAMKK2  Pathway WP4874,0.9628853240627062,0.29676113360323886,0.011223789849231548,['MAP1LC3A'],0.9997197228527197,0,0,1
449,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9636152931006545,0.5056369003982485,0.01874048999976185,"['WNT10B', 'TGFB1', 'WNT5B', 'FN1', 'STRAP']",0.9997197228527197,0,0,5
450,Amyotrophic lateral sclerosis (ALS) WP2447,0.9668751555365719,0.2865000698031551,0.009651011781598471,['BAX'],0.9997197228527197,0,0,1
451,MAPK Cascade WP422,0.9668751555365719,0.2865000698031551,0.009651011781598471,['JUN'],0.9997197228527197,0,0,1
452,Neural Crest Cell Migration in Cancer WP4565,0.9668751555365719,0.2865000698031551,0.009651011781598471,['JUN'],0.9997197228527197,0,0,1
453,ErbB signaling pathway WP673,0.9691832654958427,0.46076839826839827,0.014422768049612624,"['JUN', 'CDKN1B', 'SHC3', 'GAB1']",0.9997197228527197,0,0,4
454,Ciliary landscape WP4352,0.9702483602252854,0.6179829136944202,0.018665060790125674,"['DOCK5', 'EXOC8', 'VPS4A', 'HTRA2', 'COPS7A', 'IQGAP2', 'WDR34', 'DYNLL2', 'PSMD8', 'APMAP', 'GID8', 'VIM', 'COPS8']",0.9997197228527197,0,0,13
455,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9704363610517849,0.27692307692307694,0.008310309752909112,['ACTG1'],0.9997197228527197,0,0,1
456,Vitamin D-sensitive calcium signaling in depression WP4698,0.9704363610517849,0.27692307692307694,0.008310309752909112,['ATP2B4'],0.9997197228527197,0,0,1
457,IL-1 signaling pathway WP195,0.9710079511503046,0.3609329856951589,0.010618872977022176,"['JUN', 'IRAK3']",0.9997197228527197,0,0,2
458,Pathways affected in adenoid cystic carcinoma WP3651,0.9710079511503046,0.3609329856951589,0.010618872977022176,"['MYCBP', 'FOXP2']",0.9997197228527197,0,0,2
459,Mesodermal commitment pathway WP2857,0.9728756269236828,0.48192998696465345,0.013252606831933038,"['PRKAR1A', 'SLC2A12', 'PBX3', 'RPL38', 'TOX']",0.9997197228527197,0,0,5
460,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9736149541455741,0.2679639545513909,0.0071651894139692805,['GABRD'],0.9997197228527197,0,0,1
461,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9736149541455741,0.2679639545513909,0.0071651894139692805,['CYCS'],0.9997197228527197,0,0,1
462,Leptin signaling pathway WP2034,0.9759038752510361,0.40138136723962015,0.009790167541786911,"['LEPR', 'BAX', 'ACACB']",0.9997197228527197,0,0,3
463,G13 Signaling Pathway WP524,0.9764520123789516,0.2595647773279352,0.006185343595250359,['IQGAP2'],0.9997197228527197,0,0,1
464,Joubert Syndrome WP4656,0.977912132040206,0.39497161394971614,0.008821871706262908,"['KAT5', 'TMEM237', 'PDE6B']",0.9997197228527197,0,0,3
465,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9782982465102202,0.3387358184764992,0.007432100940228186,"['TCF7', 'ACTG1']",0.9997197228527197,0,0,2
466,PDGF Pathway WP2526,0.9812442720998525,0.2442486306263396,0.00462456626403964,['JUN'],0.9997197228527197,0,0,1
467,Common Pathways Underlying Drug Addiction WP2636,0.9850617772082563,0.23063427800269906,0.0034712584823443594,['ACTG1'],0.9997197228527197,0,0,1
468,Fragile X Syndrome  WP4549,0.985805628610907,0.46423524048324594,0.00663674183354645,"['PRKAR1A', 'CDKN2A', 'GAD1', 'GAB1', 'PPP2R5B', 'GABRD']",0.9997197228527197,0,0,6
469,Splicing factor NOVA regulated synaptic proteins WP4148,0.9866685917810079,0.2243790349053507,0.0030114065555360077,['NTNG1'],0.9997197228527197,0,0,1
470,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9905248248539427,0.2074898785425101,0.001975376307845306,['RPS6KA5'],0.9997197228527197,0,0,1
471,Ras signaling WP4223,0.9919055722747122,0.45578954786876213,0.0037043682316815272,"['SHC3', 'RASGRF2', 'GAB1', 'PLD1', 'ETS1', 'FGFR2', 'ARF6']",0.9997197228527197,0,0,7
472,Amino Acid metabolism WP3925,0.9926508661322395,0.27633711507293357,0.002038337667542635,"['LDHA', 'SRM']",0.9997197228527197,0,0,2
473,Interferon type I signaling pathways WP585,0.9932660170951029,0.19295734864890313,0.0013037662002600425,['RPS6KA5'],0.9997197228527197,0,0,1
474,Kit receptor signaling pathway WP304,0.9932660170951029,0.19295734864890313,0.0013037662002600425,['JUNB'],0.9997197228527197,0,0,1
475,mRNA Processing WP411,0.9932870268895789,0.4241400875547217,0.002856840714810722,"['PRPF4', 'LSM7', 'CPSF1', 'NCBP2', 'SRSF9', 'LSM2']",0.9997197228527197,0,0,6
476,Chemokine signaling pathway WP3929,0.9950018910335885,0.3521691074882564,0.0017645930707192712,"['SHC3', 'PRKCD', 'PTK2B', 'CXCL14']",0.9997197228527197,0,0,4
477,Thermogenesis WP4321,0.99637002451853,0.29921144431741564,0.0010881063032281773,"['LIPE', 'ADCY10', 'ACTG1']",0.9997197228527197,0,0,3
478,Integrin-mediated Cell Adhesion WP185,0.9978085455914248,0.23001080497028634,0.0005046113110832798,"['SHC3', 'ILK']",0.9997197228527197,0,0,2
479,Prolactin Signaling Pathway WP2037,0.9984671850227567,0.1479757085020243,0.00022699339617671634,['JUN'],0.9997197228527197,0,0,1
480,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.999504867890464,0.23830245180610143,0.00011802041593082313,"['RPS6KA5', 'SHC3', 'FASN']",0.9997197228527197,0,0,3
481,Genes related to primary cilium development (based on CRISPR) WP4536,0.9997197228527197,0.17965612007610457,5.0360562613509226e-05,"['CDK20', 'WDR34']",0.9997197228527197,0,0,2
